Related Experiment Video
Updated: Jun 14, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Practice patterns among United States cardiologists for managing adults with atrial fibrillation (from the AFFECTS
James A Reiffel1, Peter R Kowey, Robert Myerburg
1Columbia University, New York, NY, USA. jar2@columbia.edu
Insights
Cardiologists frequently chose rhythm control for atrial fibrillation (AF) treatment, especially in younger patients. Most AF patients in the AFFECTS registry had uncomplicated hypertension or no significant heart disease.
Area of Science:
- Cardiology
- Clinical Trials
- Atrial Fibrillation Management
Background:
- Current atrial fibrillation (AF) treatment guidelines exist from major cardiology organizations.
- Landmark clinical trials have recently influenced AF treatment strategies.
- The AFFECTS Registry examines real-world AF treatment practices.
Purpose of the Study:
- To assess current atrial fibrillation treatment strategies employed by US cardiologists.
- To evaluate treatment patterns in the context of established clinical guidelines.
- To analyze initial treatment choices (rhythm vs. rate control) in diverse AF patient populations.
Main Methods:
- The study enrolled 1,461 patients in the AFFECTS Registry.
- Initial treatment strategies were categorized as rhythm or rate control.
- Treatment patterns were analyzed based on AF type (paroxysmal vs. persistent) and patient demographics.
Main Results:
- Rhythm control was the initial strategy for 64% of all patients, and 67% of those with paroxysmal AF.
- Rhythm control assignment decreased with increasing patient age.
- Most patients received guideline-adherent antiarrhythmic drug prescriptions, with low rates of serious adverse events.
Conclusions:
- Community treatment patterns reveal a preference for rhythm control in atrial fibrillation, particularly in younger patients.
- The majority of AF patients in the registry had minimal structural heart disease or uncomplicated hypertension.
- Treatment strategies generally aligned with 2001 and 2006 guideline recommendations for antiarrhythmic drug use.
Abstract:
The Atrial Fibrillation: Focus on Effective Clinical Treatment Strategies (AFFECTS) Registry was designed to examine atrial fibrillation (AF) treatment by United States cardiologists in the context of the American College of Cardiology, American Heart Association, and European Society of Cardiology guidelines after recent landmark clinical trials. Most patients in AFFECTS had AF without clinically significant structural heart disease or only uncomplicated hypertension. Among the all-enrolled population (n = 1,461), initial treatment strategies assigned were rhythm control in 64% and rate control in 36%. Among patients with either paroxysmal (n = 1,165) or persistent (n = 273) AF, 67% and 55%, respectively, were assigned rhythm control. The trend to assign rhythm control as the initial treatment goal decreased with age. In the rhythm-control group, most patients (74%) also received a rate-control agent during the registry, while 25% of those assigned to rate control received antiarrhythmic drugs. Most first prescriptions of antiarrhythmic drugs were for first-line therapy compliant with 2001 (76%) and 2006 (86%) guidelines. Most second prescriptions were for first-line therapies as well. Rates of serious adverse events were low. In conclusion, data from this study provide insight into community treatment patterns in patients with AF, most without clinically significant structural heart disease or with only uncomplicated hypertension.
Related Concept Videos
Dysrhythmias VI: Management of Dysrhythmias
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Dysrhythmias V: Evaluating Dysrhythmias
Cardiomyopathy V: Interprofessional Care
Aortic Regurgitation III: Medical Management

